Nuclear Proliferation — 2026-07-25

Trump Conditions US-Saudi Nuclear Deal on Abraham Accords Membership as Congress Reviews Enrichment Provisions

BLUFTrump's retroactive Abraham Accords condition sets the nuclear deal on a collision course with Saudi refusal to normalize absent Palestinian statehood, leaving congressional review as the likeliest kill mechanism.

The U.S. Energy Department announced Wednesday that Energy Secretary Chris Wright and Saudi Minister of Energy Prince Abdulaziz bin Salman signed a peaceful nuclear cooperation agreement, known as a "123 agreement," and a bilateral safeguards agreement 12. The deal, expected to run 30 years, would position U.S. companies including Westinghouse to develop Saudi nuclear infrastructure and permits a two-year joint U.S.-Saudi study to determine whether domestic uranium enrichment in the kingdom is warranted 1. On Thursday, President Trump posted on Truth Social that the deal "is totally subject to" Saudi Arabia joining the Abraham Accords and stated it would not allow uranium enrichment, a condition press secretary Karoline Leavitt confirmed had not been publicly disclosed when Wright announced the signing 123. Israeli Prime Minister Benjamin Netanyahu's office welcomed the condition as "an historic leap forward for peace in the Middle East" 12. The unreleased agreement text will go to Congress for review under a 1954 law requiring congressional approval of nuclear cooperation deals, with Rep. Gregory Meeks stating the accord must include enrichment limits and IAEA Additional Protocol access 12.

Analysis
Congressional review under the 1954 nuclear cooperation law becomes the binding constraint once the Abraham Accords condition, absent from Wright's signing statement, surfaces publicly and gives Meeks and Markey a concrete demand for enrichment limits and IAEA Additional Protocol access. No named Saudi official has responded publicly to the normalization precondition, and Riyadh has resisted Abraham Accords membership for years absent a Palestinian statehood framework, leaving no observable basis for forecasting acceptance or rejection within the congressional review window. Moderate confidence reflects documented reporting of the condition's timing and content from multiple independently bylined outlets.

3 sources